ALLMedicine™ IgA Nephropathy Center
Research & Reviews 1,021 results
BMJ Case Reports; Khor C, Wong MG et. al.
Jul 29th, 2021 - A 66-year-old Asian woman presented with severe kidney injury, microscopic haematuria and subnephrotic range proteinuria with elevated serum anti-glomerular basement membrane (anti-GBM) titre. She had a history of renal cell carcinoma. Renal biops...
Nephrology, Dialysis, Transplantation : Official Publicat... Liu Y, Zhang GM et. al.
Jul 25th, 2021 - Renal fibrosis is the strongest prognosis predictor of end-stage renal disease (ESRD) in chronic kidney disease (CKD). Diffusion kurtosis imaging (DKI) is a promising method of magnetic resonance imaging (MRI) successfully used to assess renal fib...
BMC Medical Imaging; Zhang L, Chen Z et. al.
Jul 25th, 2021 - The aim of this study was to investigate the potential use of renal ultrasonography radiomics features in the histologic classification of glomerulopathy. A total of 623 renal ultrasound images from 46 membranous nephropathy (MN) and 22 IgA nephro...
https://doi.org/10.1007/s40620-021-01118-7 10.2215/CJN.07420716 10.1681/ASN.2012101017 10.1016/j.medici.2016.11.003 10.1186/s12882-018-0829-1 10.1007/s10157-015-1121-3 10.5114/aoms.2019.84690 10.1002/jcla.22226 10.1093/ndt/gfv128 10.1016/j.ajpath.2018.07.017 10.1126/science.1238522 10.1038/nsmb0217-194a 10.1038/nbt.2890 10.1111/nep.13855 10.1038/ki.2009.243 10.1016/j.kint.2017.02.003 10.1002/jcp.28201 10.12659/MSM.915658 10.1007/s10157-015-1185-0 10.1038/ki.2012.280 10.5414/CP203302 10.1016/j.bcp.2013.07.014 10.3390/toxics8040092 10.1371/journal.pone.0134451 10.1152/ajprenal.00194.2020 10.1371/journal.pone.0210213 10.3390/ijerph120708606 10.1093/ntr/ntw029 10.1093/ndt/gfz108 10.1016/j.molcel.2014.08.019 10.1016/j.tig.2016.03.002 10.1042/CS20150711 10.1074/jbc.M114.555052 10.3389/fimmu.2018.00504 10.1016/j.intimp.2019.02.056 10.1016/j.ccell.2019.01.001 10.1016/j.ymgme.2019.04.012 10.1158/1078-0432.CCR-19-2230 10.1016/j.kint.2019.08.022 10.1016/j.ccell.2018.02.003 10.1158/1078-0432.CCR-20-1741 10.3389/fgene.2019.00192
Journal of Nephrology; Luan R, Tian G et. al.
Jul 23rd, 2021 - There are arguments for individualized treatments and the necessity of non-invasive biomarkers for patients with IgA nephropathy (IgAN) according to gender, but the rationale remains unclear. We aimed to investigate the relationship between urine ...
Gene Yang K, Zhang Y et. al.
Jul 19th, 2021 - Immunoglobulin A nephropathy (IgAN) is the most common primary glomerular disease worldwide. It accounts for approximately 30 ~ 40% of glomerular diseases in China. However, the exact pathogenesis of IgAN is not well established. This study aimed ...
Guidelines 1 results
Clinical and Experimental Nephrology; Yuzawa Y, Yamamoto R et. al.
Apr 21st, 2016 - Evidence-based clinical practice guidelines for IgA nephropathy 2014.|2016|Yuzawa Y,Yamamoto R,Takahashi K,Katafuchi R,Tomita M,|diagnosis,etiology,therapy,
Clinicaltrials.gov 45 results
Jan 27th, 2020 - IgA nephropathy (IgAN) is a histologically defined glomerulonephritis (renal biopsy) by the presence of deposits immunoglobulin A (IgA) in the renal mesangium (at least 1+) by immunofluorescence. The clinic allows excluding secondary forms (10-15%...
Dec 24th, 2019 - This multi-center, open-label Phase 2 trial will study the safety, tolerability, and efficacy of bardoxolone methyl in qualified patients with the following rare chronic kidney diseases (CKD): CKD associated with type 1 diabetes (T1D), IgA nephrop...
Sep 6th, 2018 - The effect of tonsillectomy therapy on IgA nephropathy is still controversial.Few prospective,randomized investigations have examined how tonsillectomy affects the shortterm and longterm renal outcome of IgA nephropathy.This is A prospective,rando...
Sep 6th, 2018 - The investigators are registering all biopsy-proven primary IgA nephropathy (IgAN) patients, and developing a IgAN database in China. Patients' demographic characteristics (including age, gender, height, weight, BMI, smoking, drinking, and educati...
Mar 23rd, 2018 - Hepatitis C virus infection is a major public health problem with an estimated global prevalence of 3% and an estimated 5-20% of infected patients will develop liver cirrhosis .The Prevalence of Hepatitis C infection in end stage renal disease is ...
News 25 results
Jun 9th, 2021 - A first-in-class oral inhibitor of the alternative complement pathway that drives the pathogenesis of primary glomerulonephritis, iptacopan (LNP023, Novartis), is showing early promise as the first targeted therapy for the treatment of IgA nephrop...
Apr 20th, 2021 - Treatment with the sodium-glucose cotransporter-2 (SGLT2) inhibitor dapagliflozin (Farxiga) was safe and effective for slowing progression of chronic kidney disease (CKD) and the development of end-stage renal disease for patients with immunoglobu...
MDedge Family Medicine;
Jan 16th, 2020 - The rash was consistent with nonblanching purpura. Two punch biopsies were performed for hematoxylin and eosin stain and direct immunofluorescence, which were consistent with IgA mediated small vessel vasculitis, or Henoch-Schoenlein purpura.
Mark S. Lesney
Oct 23rd, 2018 - Chronic viral infection can be associated with a variety of autoimmune kidney diseases, according to a review published in Rheumatic Disease Clinics. London_England/Thinkstock In particular, hepatitis C virus (HCV) infection can cause several kidn.
Aug 7th, 2017 - A high rate of serious adverse events led to the premature termination of a clinical trial designed to evaluate the efficacy of oral methylprednisolone in patients with immunoglobulin A (IgA) nephropathy despite evidence of a statistically signifi...